This week, we leave central Spain and head North-East, across the Pyrenees and head to the largest city in ‘Traditional Brittany’, France, and also the this week’s location, Nantes. This picturesque city was voted the most Green in EU (2013), is famous for the production of Muscadet wine and is home to our biotech of the week, Effimune.
City: Nantes, France
Employees: 13 (as of 12/2015)
Financial Data: €1.07M Total Raised (as of 01/2016)
Mission: Effimune is a French Biotech with it’s primary focus on the research and development of drug candidates for transplant and immune-mediated diseases, making it one of the largest EU research and clinical centers in transplant immunology. It currently has 2 main products in its pipeline, Effi-7, a humanized monoclonal antibody that dampens the IL-7 pathway, a major factor in the pathophysiology of autoimmune diseases (e.g. ulcerative colitis) and hematologic cancers, this is currently showing positive signs in preclinical trials.